EMBioSys
PrivateLast Round
Grant
Nov 25, 2025
Total Funding Raised
$1.59M
Company Overview
EMBioSys is a medical technology company that develops non-invasive, wearable garments using induced electric field (iEF) therapy to treat aggressive cancers like triple-negative breast cancer.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EMBioSys Comps
Public and private peers based on sector, stage, and business model.
EMBioSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 25, 2025 | ||||
| Seed | Apr 30, 2025 | ||||
| Grant | May 9, 2024 |
EMBioSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Received $1.38M from National Cancer Institute and NIH RADx.
- Apr 30, 2025
Raised $3M in a seed funding round.
EMBioSys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EMBioSys's valuation, stock price, and market status.
Firmographic Details
HeadquartersBoston, Massachusetts
Year Founded2022
Last FundingNov 25, 2025
